Early experience with Eleveld: Practical tips transitioning to Eleveld Propofol Target-Controlled Infusion (TCI)
Many Anaesthetists interested in intravenous anaesthesia will be aware of the various pharmacokinetic (PK) models for Propofol such as Schnider, Marsh, Kataria and Paedfusor.
The advent of the Eleveld Targeted Control Infusion (TCI) model gives clinicians new possibilities to optimise dosing across broader clinical situations, from neonates to the elderly and high Body Mass Index (BMI) individuals. More importantly, this is achieved whilst maintaining stable and predictable concentrations.
To help optimise the use of this model, this workshop session is designed to provide participants the following:
1. Understand the kinetics and the demographic support behind the model, as well as its limitations
2. Ensure differences between Eleveld, Schnider and Marsh TCI models are understood
3. Share early user experience with the use of Eleveld TCI model, as well as recommendations and watchouts
4. Provide simulated, hands-on dosing scenarios for paediatric, adults, the elderly and obese patients to understand potential clinical effects